GlassScriptPhysician profile
George Deimel
NPI 1669603064
$25,523.77
in general payments reported to CMS, 2019-2025
26 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what 76% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,164 · 2020: $1,294 · 2021: $5,333 · 2022: $1,032 · 2023: $2,907 · 2024: $4,581 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,550 · Food and Beverage: $4,131 · Education: $19.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,550.26 |
| Food and Beverage | $4,130.97 |
| Education | $19.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $5,597.94 | 2019-2020 | |
| Boston Scientific Corporation | $5,280.75 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Fixate |
| Medtronic, INC. | $3,302.28 | 2021-2025 | Inceptiv, Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $3,125.06 | 2019-2025 | Proclaim, Eterna, Octrode |
| Saluda Medical Americas, INC. | $2,933.54 | 2024-2025 | Evoke |
| Pacira Pharmaceuticals Incorporated | $1,701.50 | 2021-2024 | Iovera, Zilretta |
| Stryker Corporation | $1,143.69 | 2019-2025 | Mild Device Kit |
| Vertos Medical, INC. | $1,080.64 | 2019-2021 | |
| Abbvie INC. | $286.46 | 2022-2025 | Botox |
| Nevro Corp. | $207.52 | 2019-2022 | |
| Globus Medical, INC. | $184.99 | 2025 | Senza, Vyrsa V1 |
| Horizon Therapeutics Plc | $140.80 | 2020-2021 | |
| Midsouth Orthopedics INC. | $117.00 | 2020 | |
| Pacira Therapeutics, INC. | $78.43 | 2019-2021 | |
| Spr Therapeutics, INC | $69.19 | 2022-2023 | Sprint Pns System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $38.38 | 2023 | Irrisept |
| Painteq LLC | $36.76 | 2022-2024 | Painteq |
| Djo, LLC | $28.81 | 2024 | Cmf |
| Pfizer INC. | $25.78 | 2019-2020 | |
| Nalu Medical, INC. | $24.85 | 2022 | |
| Spine Wave, INC. | $22.75 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.13 | 2025 | |
| Radius Health, INC. | $20.60 | 2021 | |
| Baudax Bio INC. | $19.78 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.76 | 2024 | Givlaari |
| Amgen INC. | $14.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Deimel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.